Selected research
Industry Research
Antiviral Drug Packaging Industry Research Report 2026
Market perspective
The global Antiviral Drug Packaging market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Antiviral Drug Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Antiviral Drug Packaging is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Antiviral Drug Packaging is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Antiviral Drug Packaging include Avery Dennison Corporation, E.I. du Pont de Nemours, CCL Industries Inc, BioCote, Avient, Mondi, Biomaster, BASF and Lonza, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Antiviral Drug Packaging market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Antiviral Drug Packaging Market by Company
Avery Dennison Corporation
E.I. du Pont de Nemours
CCL Industries Inc
BioCote
Avient
Mondi
Biomaster
BASF
Lonza
Takex Labo Co. Ltd
Berry
Lageen Tubes.
Antiviral Drug Packaging Segment by Type
Rigid Plastic
Flexible Blister Foils
Others
Antiviral Drug Packaging Segment by Application
Pharmaceuticals
Healthcare
Antiviral Drug Packaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiviral Drug Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antiviral Drug Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiviral Drug Packaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Antiviral Drug Packaging manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Antiviral Drug Packaging by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Antiviral Drug Packaging in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Rigid Plastic
- Flexible Blister Foils
- Others
Applications
- Pharmaceuticals
- Healthcare
Companies covered
- Avery Dennison Corporation
- E.I. du Pont de Nemours
- CCL Industries Inc
- BioCote
- Avient
- Mondi
- Biomaster
- BASF
- Lonza
- Takex Labo Co. Ltd
- Berry
- Lageen Tubes.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Antiviral Drug Packaging Market Size (2021-2032)
- 2.2.2 Global Antiviral Drug Packaging Sales (2021-2032)
- 2.2.3 Global Antiviral Drug Packaging Market Average Price (2021-2032)
- 2.3 Antiviral Drug Packaging by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Rigid Plastic
- 2.3.3 Flexible Blister Foils
- 2.3.4 Others
- 2.4 Antiviral Drug Packaging by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceuticals
- 2.4.3 Healthcare
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Antiviral Drug Packaging Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Antiviral Drug Packaging Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Antiviral Drug Packaging Revenue of Manufacturers (2021-2026)
- 3.4 Global Antiviral Drug Packaging Average Price by Manufacturers (2021-2026)
- 3.5 Global Antiviral Drug Packaging Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Antiviral Drug Packaging, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Antiviral Drug Packaging, Product Type & Application
- 3.8 Global Manufacturers of Antiviral Drug Packaging, Established Date
- 3.9 Global Antiviral Drug Packaging Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Avery Dennison Corporation
- 4.1.1 Avery Dennison Corporation Company Information
- 4.1.2 Avery Dennison Corporation Business Overview
- 4.1.3 Avery Dennison Corporation Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Avery Dennison Corporation Antiviral Drug Packaging Product Portfolio
- 4.1.5 Avery Dennison Corporation Recent Developments
- 4.2 E.I. du Pont de Nemours
- 4.2.1 E.I. du Pont de Nemours Company Information
- 4.2.2 E.I. du Pont de Nemours Business Overview
- 4.2.3 E.I. du Pont de Nemours Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 E.I. du Pont de Nemours Antiviral Drug Packaging Product Portfolio
- 4.2.5 E.I. du Pont de Nemours Recent Developments
- 4.3 CCL Industries Inc
- 4.3.1 CCL Industries Inc Company Information
- 4.3.2 CCL Industries Inc Business Overview
- 4.3.3 CCL Industries Inc Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 CCL Industries Inc Antiviral Drug Packaging Product Portfolio
- 4.3.5 CCL Industries Inc Recent Developments
- 4.4 BioCote
- 4.4.1 BioCote Company Information
- 4.4.2 BioCote Business Overview
- 4.4.3 BioCote Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 BioCote Antiviral Drug Packaging Product Portfolio
- 4.4.5 BioCote Recent Developments
- 4.5 Avient
- 4.5.1 Avient Company Information
- 4.5.2 Avient Business Overview
- 4.5.3 Avient Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Avient Antiviral Drug Packaging Product Portfolio
- 4.5.5 Avient Recent Developments
- 4.6 Mondi
- 4.6.1 Mondi Company Information
- 4.6.2 Mondi Business Overview
- 4.6.3 Mondi Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mondi Antiviral Drug Packaging Product Portfolio
- 4.6.5 Mondi Recent Developments
- 4.7 Biomaster
- 4.7.1 Biomaster Company Information
- 4.7.2 Biomaster Business Overview
- 4.7.3 Biomaster Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Biomaster Antiviral Drug Packaging Product Portfolio
- 4.7.5 Biomaster Recent Developments
- 4.8 BASF
- 4.8.1 BASF Company Information
- 4.8.2 BASF Business Overview
- 4.8.3 BASF Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 BASF Antiviral Drug Packaging Product Portfolio
- 4.8.5 BASF Recent Developments
- 4.9 Lonza
- 4.9.1 Lonza Company Information
- 4.9.2 Lonza Business Overview
- 4.9.3 Lonza Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Lonza Antiviral Drug Packaging Product Portfolio
- 4.9.5 Lonza Recent Developments
- 4.10 Takex Labo Co. Ltd
- 4.10.1 Takex Labo Co. Ltd Company Information
- 4.10.2 Takex Labo Co. Ltd Business Overview
- 4.10.3 Takex Labo Co. Ltd Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Takex Labo Co. Ltd Antiviral Drug Packaging Product Portfolio
- 4.10.5 Takex Labo Co. Ltd Recent Developments
- 4.11 Berry
- 4.11.1 Berry Company Information
- 4.11.2 Berry Business Overview
- 4.11.3 Berry Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Berry Antiviral Drug Packaging Product Portfolio
- 4.11.5 Berry Recent Developments
- 4.12 Lageen Tubes.
- 4.12.1 Lageen Tubes. Company Information
- 4.12.2 Lageen Tubes. Business Overview
- 4.12.3 Lageen Tubes. Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Lageen Tubes. Antiviral Drug Packaging Product Portfolio
- 4.12.5 Lageen Tubes. Recent Developments
5 Global Antiviral Drug Packaging Market Scenario by Region
- 5.1 Global Antiviral Drug Packaging Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Antiviral Drug Packaging Sales by Region: 2021-2032
- 5.2.1 Global Antiviral Drug Packaging Sales by Region: 2021-2026
- 5.2.2 Global Antiviral Drug Packaging Sales by Region: 2027-2032
- 5.3 Global Antiviral Drug Packaging Revenue by Region: 2021-2032
- 5.3.1 Global Antiviral Drug Packaging Revenue by Region: 2021-2026
- 5.3.2 Global Antiviral Drug Packaging Revenue by Region: 2027-2032
- 5.4 North America Antiviral Drug Packaging Market Facts & Figures by Country
- 5.4.1 North America Antiviral Drug Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Antiviral Drug Packaging Sales by Country (2021-2032)
- 5.4.3 North America Antiviral Drug Packaging Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Antiviral Drug Packaging Market Facts & Figures by Country
- 5.5.1 Europe Antiviral Drug Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Antiviral Drug Packaging Sales by Country (2021-2032)
- 5.5.3 Europe Antiviral Drug Packaging Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Antiviral Drug Packaging Market Facts & Figures by Country
- 5.6.1 Asia Pacific Antiviral Drug Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Antiviral Drug Packaging Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Antiviral Drug Packaging Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Antiviral Drug Packaging Market Facts & Figures by Country
- 5.7.1 South America Antiviral Drug Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Antiviral Drug Packaging Sales by Country (2021-2032)
- 5.7.3 South America Antiviral Drug Packaging Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Antiviral Drug Packaging Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Antiviral Drug Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Antiviral Drug Packaging Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Antiviral Drug Packaging Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Antiviral Drug Packaging Sales by Type (2021-2032)
- 6.1.1 Global Antiviral Drug Packaging Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Antiviral Drug Packaging Sales Market Share by Type (2021-2032)
- 6.2 Global Antiviral Drug Packaging Revenue by Type (2021-2032)
- 6.2.1 Global Antiviral Drug Packaging Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Antiviral Drug Packaging Revenue Market Share by Type (2021-2032)
- 6.3 Global Antiviral Drug Packaging Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Antiviral Drug Packaging Sales by Application (2021-2032)
- 7.1.1 Global Antiviral Drug Packaging Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Antiviral Drug Packaging Sales Market Share by Application (2021-2032)
- 7.2 Global Antiviral Drug Packaging Revenue by Application (2021-2032)
- 7.2.1 Global Antiviral Drug Packaging Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Antiviral Drug Packaging Revenue Market Share by Application (2021-2032)
- 7.3 Global Antiviral Drug Packaging Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Antiviral Drug Packaging Value Chain Analysis
- 8.1.1 Antiviral Drug Packaging Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Antiviral Drug Packaging Production Mode & Process
- 8.2 Antiviral Drug Packaging Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Antiviral Drug Packaging Distributors
- 8.2.3 Antiviral Drug Packaging Customers
9 Global Antiviral Drug Packaging Analyzing Market Dynamics
- 9.1 Antiviral Drug Packaging Industry Trends
- 9.2 Antiviral Drug Packaging Industry Drivers
- 9.3 Antiviral Drug Packaging Industry Opportunities and Challenges
- 9.4 Antiviral Drug Packaging Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst